Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Seems to limit the amount to be sold under each put notice to 9.99% of outstanding shares plus shs to be issued. So it would seem that the full $10,000,000 would not go all at once. Ultimately, the result of the use of this money will determine if dilution takes place. The issuance of stock at an 8% discount to market would have minimal impact on share price as it now stands. However, if they can in fact generate substantial profitable business globally by using this money, we may not see a dilutive effect. Only time will tell.
Med and tytlf
Have you read through the agreement? How do you interpret Section 7.2(h)?
http://www.sec.gov/Archives/edgar/data/1114605/000114420411006360/v210270_ex10-2.htm
luv,
Is that true about the bond not being posted and therefore no recall? Any link?
Unless I'm missing something, looks like 70 to 80.
http://ecrm.marketgate.com/Events/Event.aspx?s=1752&sec=4
Interesting concept. Take a look at the site and judge for yourself.
http://www.marketgate.com/marketgate/default.aspx
I think you may want to read a little more carefully:
"Kidz-Med asserts that a recall would involve about 4,000 units, spanning five retailers with more than 1,000 stores."
Also, there was a wide disparity between Tirrota's estimate of the costs and Technimed's estimate. I'm sure each side's attorneys
used numbers favorable to their case, so the truth is probably somewhere in the middle.
But I guess you knew all that since you read it.
Doesn't sound that horrible to me. Once a change in packaging is made,(which I believe has already happened)they are good to go.
Plaintiffs’ motion for a preliminary injunction is GRANTED.
CONCLUSION
It is hereby ORDERED that:
(1) Defendants Kidz-Med, Inc. and American Scientific Resources, Inc., and their officers, agents, servants, employees, and attorneys and all persons in active concert or participation with any of them who receive actual notice of this order by personal service or otherwise be and they hereby are enjoined and restrained, pending the hearing and determination of this action, from marketing or selling the new Kidz-Med non-contact thermometer using words, symbols, trade dress are any combination thereof that are likely to cause confusion between the Thermofocus 5-in-1 and Kidz-Med’s new non-contact thermometer, including using the current packaging for the Kidz-Med product. Within five (5) business days of the issuance of this memorandum opinion and order, the parties shall submit a proposed order specifying the changes in packaging that Kidz-Med will observe in order to eliminate this risk.
(2) It is further ORDERED that, within seven (7) business days from the date of this order, Kidz-Med shall notify in writing each customer to whom it has sold or distributed the Kidz-Med non-contact thermometer in the confusing trade dress that the thermometer has
been recalled pursuant to the order of this Court, requesting that the addressee immediately
cease the sale or distribution of the product and that it return all product in its possession,
custody, or control to Kidz-Med pending Kidz-Med's replacement of the packaging with noninfringing
packaging, and offering to reimburse the addressee for the reasonable costs incurred
in doing so.
Dated: New York, New York
January 18,2011
SO ORDERED.
___ fr;J~~
Paul G. Gardephe
United States District Judge
33
Could be.
Has anyone seen the actual court documents, not the p/r put out by Technimed's attorneys. It's my understanding that a change of packaging is all that is required. Sounds like the company has already dealt with this.
4th quarter filing (10K) due by March 31, 2011.
Please spare us.
Remember this:
doggone Share Tuesday, December 21, 2010 1:37:25 PM
Re: makeamint2 post# 47949 Post # of 48233
ASR is pretty much already a virtual environment, looks to me anyawy, always has been. Not sure how they could do without the warehouse, need a place to store and complete assembly of product.
I have never been sold on the market demand (after extensive DD) for any of the products held by ASFX so i can't be easily convinced that new management would make any significant difference in the long term. ASFX is pink sheet stock and will never be anything but, IMO. SDog
Not sure, but I believe it was mentioned not long ago that it took a little over a couple of weeks for someone who had been through this previously.
Now we just have to wait for the market maker to get the uplist.
That was quick. Must be getting down to the last item(s).
Very true.
Page 16 of S-1/A
Our common stock is quoted on the Pink Sheets under the symbol “ASFX.PK”. A market maker has agreed to file an application with FINRA on our behalf so as to be able to quote the shares of our common stock on the Over-the-Counter Bulletin Board maintained by FINRA. There are no assurances that the application will be accepted by FINRA nor can we estimate as to the time period that the application process will require. We are not permitted to file such application on our own behalf. If an application is accepted, we cannot predict the extent to which investor interest in us will lead to the development of an active, liquid trading market. Active trading markets generally result in lower price volatility and more efficient execution of buy and sell orders for investors. There is no assurance that our common stock will trade at market prices in excess of the initial public offering price as prices for the common stock in any public market which may develop will be determined in the marketplace and may be influenced by many factors, including the depth and liquidity of the market for the common stock, investor perception of us and general economic and market conditions.
luv, I like this part:
Sol-Millennium: The Sol-Millennium Group is a leading and innovative products and services company that specializes in the development, manufacturing and distribution of advanced user-friendly safety medical products.
The Company has two operating entities including Sol-Millennium Medical Products Co., LTD based in Shanghai and Zhejiang Sol-Millennium Plastic Mould Co., LTD. headquartered in Zhejiang Province, China. Since their establishment more than 20 years ago, they have dedicated themselves to provide world leading safety injection solutions.
They are the largest and most experienced syringe mould producer in China meeting over 60% of China’s syringe mould needs. Sol-Millennium is officially an approved supplier for UNICEF (United Nations Children’s Fund) and many other multinational NGO’s.
ASR’s thermometers and NGO Disintegrator unit will be shipping to this distributor in 2011. ASR has been collaborating with Sol-Millennium on developing the Disintegrator NGO version for third world and
Thanks med, just gets old reading the same nonsense day in and day out.
It appears that is your view.
I have read your posts. Not sure what they prove. You consistently try to apply large company metrics to a company that has gone throught drastic change in the last couple of years and is just coming to market with new products. I, as do others here know what the risks are. There is tremendous debt, which the company may never get over. The new products may never sell enough to turn things around. The company management may be lying. It wouldn't be the first time for a pink sheet company. You're not educating anybody here genius! Save your sanctimonious attitude for someone else!
Oh it is, maybe you need to go back to science class.
Isn't a reflection the exact opposite of what it appears to be?
My thoughts exactly. Excellent post!
Latest S-1 A is out, but it still only has financial info through June 30 2010.
Thank you for your effort.
I believe that by filing the S-1A's they are meeting the reporting requirements. So their statement that they are compliant appears to be accurate.
I believe the info in the S-1A exceeds the requirements of the Q, so as long as they file the S-1 A they should be in compliance if/when the uplist occurs. They have not been filing Q's and K per se, but again, I believe the info in the S-1A covers them.
I don't believe pinkies are required to file a Q. However, we should see an updated S-1A with all the financial info. Once they are uplisted Q's and K will need to be filed.
Congrats Dr. P!
The distribution agreement contained the non compete clause. Under item 2. the distribution agreement is terminated as of the date of the settlement agreement. Pretty clear.
As was stated, the covenant not to compete in the distribution agreement is null and void. Tecnimed appears to be barking up the wrong tree.
Exergen suits relate to Thermofocus which ASFX is phasing out.
These suits may cost some money for legal fees, but I don't see much beyond that IMHO.
See item 2. of the settlement agreement:
http://www.sec.gov/Archives/edgar/data/1114605/000114420410025531/v183917_ex10-53.htm
Okay, so your point is?
The warrant price adjusts based on the increase or decrease in o/s shares. It's still higher than the current price or adjusted price whether there be further dilution and/or a reverse split as you claim will happen.
Yes it will. Just wanted to make sure everyone saw all the info as opposed to the selective info you provide.
Also from the S-1A:
The Company is no longer bound by any non-compete agreement with Tecnimed, since the Settlement Agreement completely superseded the Distribution Agreement.
The company would be required not is or has been. Also you conveniently failed to mention that the price of the stock would have to go up in order for it to make sense to exercise the options/warrants.
Again, just your opinion Robert, nothing more.
Your so called "facts" continue to be stretching the truth. You claim it a "fact" that ASFX is overdrawn by 500 million shares. The fact is they are not overdrawn. There are warrants/options that if exercised would cause them to be overdrawn. This has not happened yet. The company has accrued a liability for the possibility of this happening. Please get your so called facts straight.
Not totally certain Rookie. They have been including them in the S-1A filings. If the uplisting occurs, then I think they are required to start remitting Q's and K. The Q for the quarter ended September 30, 2010 would be due November 15th.